Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-02-24 @ 6:33 PM
Study NCT ID:
NCT05329220
Status:
COMPLETED
Last Update Posted:
2025-02-24
First Post:
2022-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2
Sponsor:
Bavarian Nordic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-05
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-25
First Submit QC Date:
None
Study First Post Date:
2022-04-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-19
Results First Submit QC Date:
None
Results First Post Date:
2025-02-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-02-24
Last Update Post Date Type:
ACTUAL